marijuana stocks news

Online Publication Retracts Headline Implying Medbox is Under Investigation

Medbox’s corporate attorney demanded a retraction from and for reporting false information; Majority shareholder confirms Medbox is not under any SEC investigation

LOS ANGELES, CA / ACCESSWIRE / November 6, 2014 / P. Vincent Mehdizadeh – Founder and Majority shareholder of Medbox, Inc. (OTCQB: MDBX) commented today that online publications, and retracted a headline that incorrectly asserted that Medbox is under investigation by the SEC.

“I am personally relieved that the headline and key pieces of the article were corrected,” commented Mehdizadeh. “However, the damage to investor confidence yesterday was substantial and I am meeting with my legal team to discuss possible remedies available to make an example out of this online publication and to ensure incorrect information is never disclosed about the company again.”

The article overshadowed the big news of the day, which was that voters across the country have accelerated the unprecedented momentum to legalize marijuana and end the wider drug war, with marijuana legalization measures passing in Oregon, Washington, D.C., and Alaska.

Mehdizadeh continued, “A big congratulations is in order to my friends at Drug Policy Alliance, Marijuana Policy Project, and Americans for Safe Access for their continued contributions to the industry.”

About P. Vincent Mehdizadeh, Founder and Senior Strategist at Medbox, Inc.

P. Vincent Mehdizadeh founded Medbox’s main subsidiary, Medicine Dispensing Systems, in February 2008. He commenced operations for that company in 2010, and in December of 2011 sold that company to what became Medbox, Inc. Mr. Mehdizadeh served as senior consultant from December 2012 until May 10, 2013 for Medbox, Inc. and then transitioned to Chief Operations Officer and Board Chairman for Medbox, Inc. through May of 2014. Mr. Mehdizadeh currently serves as the company’s Senior Strategist and Founder. Mr. Mehdizadeh was responsible for creating the 2 main patents behind the company’s technology, helping to assemble the talented management team at Medbox, and also developing the concept behind the business models driving revenue for the company. Currently Mr. Mehdizadeh has stepped into a consulting role at Medbox and assists with sourcing clients, conducting seminars, media interviews, and public speaking engagements on behalf of the Company, as well as engaging other companies in discussions aimed at developing synergies between those companies and Medbox. Over the last two years Mehdizadeh has donated over $2 million dollars to Americans for Safe Access, Drug Policy Alliance, Marijuana Policy Project, and St. Jude Children’s Research Hospital.


RAH Marketing

SOURCE: Medbox, Inc.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$EDXC Launches CBD Soft Chews for Dogs

Endexx Launches CBD Soft Chews for Dogs Endexx Corporation ( OTC PINK…

$CBDS Patent Pending Strain

Cannabis Sativa Inc and THC Farmaceuticals’ Subsidiary, Terpene Research Labs (TRL) to…

$CARA to Announce First Quarter 2017 Financial Results on May 4, 2017

Cara Therapeutics to Announce First Quarter 2017 Financial Results on May 4,…